Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DENTSPLY SIRONA Inc (IT:1XRAY)
MILAN:1XRAY
Holding IT:1XRAY?
Track your performance easily
1XRAY Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€16.23 - €34.32
Previous Close€18
Volume0.00
Average Volume (3M)405.00
Market Cap
€3.64B
Enterprise Value€5.58B
Total Cash (Recent Filing)$296.00M
Total Debt (Recent Filing)$2.32B
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Feb 26, 2025EPS Estimate
€0.41Last Dividend Ex-Date
Dec 27, 2024Dividend Yield3.27%
Share Statistics
EPS (TTM)-1.88
Shares Outstanding198,779,568
10 Day Avg. Volume6
30 Day Avg. Volume405
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.47
Price to Sales (P/S)1.20
Price to Cash Flow (P/CF)8.30
P/FCF Ratio12.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.43
Enterprise Value/Gross Profit2.68
Enterprise Value/Ebitda-22.51
Forecast
1Y Price Target
€22.38Price Target Upside24.35% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
DENTSPLY SIRONA News
PremiumCompany Announcements
Dentsply Sirona Appoints Interim CFO Amid Investigation
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDENTSPLY SIRONA generated $951 million in net sales versus our estimate of $942 million in the quarter, indicating stronger-than-expected financial results.
Market PositionDespite weak sentiment, the longer-term risk/reward continues to favor investment at the current valuation, suggesting potential for future reassessment.
Product InnovationXRAY recently launched its next-generation intraoral scanner, Primescan 2, the first cloud-native wireless scanner, touting its portability, hardware independence, communication, computation, and simulation features.
Bears Say
Financial GuidanceManagement lowered its FY/24 financial guidance outlook for the second consecutive quarter.
Regulatory RisksXRAY disclosed risk of regulatory action by the FDA, including fines and injunctions, due to issues with its Byte aligners.
Tax InvestigationThe disclosure that federal and local authorities, along with tax investigators, arrived at XRAY's main German offices raised concerns.
---
1XRAY FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
DENTSPLY SIRONA Inc lowest stock price was €16.23 and its highest was €34.32 in the past 12 months.
What is DENTSPLY SIRONA Inc’s market cap?
Currently, no data Available
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is Feb 26, 2025 which is in 55 days.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
DENTSPLY SIRONA Inc released its earnings results on Nov 07, 2024. The company reported €0.483 earnings per share for the quarter, beating the consensus estimate of €0.458 by €0.025.
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Undervalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc pays a Quarterly dividend of €0.153 which represents an annual dividend yield of 3.27%. See more information on DENTSPLY SIRONA Inc dividends here
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is €0.41.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 198,779,570 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
DENTSPLY SIRONA Inc reported an EPS of €0.483 in its last earnings report, beating expectations of €0.458. Following the earnings report the stock price went down -24.092%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Among the largest hedge funds holding DENTSPLY SIRONA Inc’s share is First Eagle Investment Management LLC. It holds DENTSPLY SIRONA Inc’s shares valued at 383M.
---
DENTSPLY SIRONA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€22.38 (24.35% Upside)
€22.38 (24.35% Upside)
Blogger Sentiment
Bullish
IT:1XRAY Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $310.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.28%
12-Months-Change
Fundamentals
Return on Equity
-14.08%
Trailing 12-Months
Asset Growth
-7.99%
Trailing 12-Months
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in York, PA.
---
1XRAY Company Deck
---
1XRAY Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant achievements in digital innovation and operational efficiencies, such as the Primescan 2 launch and ERP deployment. However, these were overshadowed by regulatory issues and financial challenges, notably with Byte, leading to a cautious outlook. The sentiment is cautious due to the balance of positive innovations against substantial operational and market pressures.Read More>---
1XRAY Net sales Breakdown
37.02% Essential Dental Solutions
17.68% Implants & Prosthetics
15.84% Equipment & Instruments
13.64% CAD/CAM
15.81% Other
---
1XRAY Stock 12 Month Forecast
Average Price Target
€22.38
▲(24.35% Upside)
Technical Analysis
DENTSPLY SIRONA
―
Align Tech
―
Henry Schein
―
Zimmer Biomet Holdings
―
Smith & Nephew Snats
―
Best Analysts Covering 1XRAY
1 Year
1 Year Success Rate
11/20 ratings generated profit
1 Year Average Return
-0.36%
reiterated a buy rating 10 months ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 55.00% of your transactions generating a profit, with an average return of -0.36% per trade.
---